Research & Development



  正在看書的雲瑯放下書本道︰“雲氏一個都不要。”   雲瑯坐在錦榻上,給老虎抓癢,听卓姬這樣說,雲瑯的臉又垮下來了。俺来撸   夏侯靜揮揮衣袖道︰“去,去,就這麼辦,錢財若是不足,老夫會從家中調撥。”俺要撸   “已經來了,再有一刻就會抵達雲氏大門。”   甦稚幸福的嘆口氣,將自己的腳翹起來,得意的道︰“以後就這麼過日子,多好。”夜射猫精品在线av   雲瑯悲傷地道︰“我忽然發現,讓一個家族壯大的最有效武器其實就是女人的肚皮,古人說的好啊,多生孩子,多養豬,誠為真理。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo